Home LiteratureArticle Details
PMID: 23255112 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Regulation of miR106b cluster through the RB pathway: mechanism and functional targets.

Cell cycle (Georgetown, Tex.) ·Vol. 12 ·No. 1 ·2013-01-01 ·Pages 98-111

Thangavel C, Boopathi E, Ertel A, Lim M, Addya S, Fortina P, Witkiewicz AK, Knudsen ES

Abstract

The RB pathway plays a critical role in proliferation control that is commonly subverted in tumor development. However, restoration of RB pathway function can be elicited in many tumor cells by the inhibition of CDK4/6 activity that leads to dephosphorylation of RB and subsequent repression of E2F-mediated transcription. In this context, active RB/E2F complexes inhibit the expression of a critical program of coding genes that promote cell cycle progression. However, the non-coding RNA target genes downstream from RB that could be relevant for tumor biology remain obscure. Here, miRNA gene expression profiling identified the miR106b cluster as being efficiently repressed with CDK4/6 inhibition in an E2F and RB-dependent manner. Importantly, the miR106B-cluster is intragenic of MCM7, and through a series of functional studies, the basis of MCM7 regulation and concordant expression of the miRNA species within the 106b cluster was determined. Importantly, RB-mediated repression of the 106b cluster enhances the transcript levels of p21Cip1 and PTEN. These data provide a mechanistic basis for cross-talk between the RB pathway and p21 and PTEN through the regulation of the MCM7/miR106b locus.

MeSH Terms
Cell Cycle Proteins/genetics,metabolism Cell Line, Tumor Cluster Analysis Cyclin-Dependent Kinase 4/antagonists & inhibitors,metabolism Cyclin-Dependent Kinase 6/antagonists & inhibitors,metabolism Cyclin-Dependent Kinase Inhibitor p21/genetics,metabolism DNA-Binding Proteins/genetics,metabolism E2F Transcription Factors/genetics,metabolism Humans MCF-7 Cells MicroRNAs/metabolism Minichromosome Maintenance Complex Component 7 Multigene Family Nuclear Proteins/genetics,metabolism PTEN Phosphohydrolase/genetics,metabolism Promoter Regions, Genetic Retinoblastoma Protein/genetics,metabolism Signal Transduction
Chemicals
Cell Cycle Proteins Cyclin-Dependent Kinase Inhibitor p21 DNA-Binding Proteins E2F Transcription Factors MIRN106 microRNA, human MicroRNAs Nuclear Proteins Retinoblastoma Protein Cyclin-Dependent Kinase 4 Cyclin-Dependent Kinase 6 PTEN Phosphohydrolase MCM7 protein, human Minichromosome Maintenance Complex Component 7
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Thangavel Chellappagounder
Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Boopathi Ettickan
Ertel Adam
Lim Meng
Addya Sankar
Fortina Paolo
Witkiewicz Agnieszka K
Knudsen Erik S
References (49)
49 references, click to expand
  1. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression.
    Mol Cell Biol. 2008 Apr;28(7):2167-74 PMID: 18212054
  2. RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response.
    Cell Cycle. 2010 Oct 15;9(20):4153-63 PMID: 20948315
  3. Allosteric regulation of Argonaute proteins by miRNAs.
    Nat Struct Mol Biol. 2010 Feb;17(2):144-50 PMID: 20062058
  4. Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function.
    Oncogene. 2007 Sep 20;26(43):6307-18 PMID: 17452985
  5. Cloning and characterization of human MCM7 promoter.
    Gene. 1998 Aug 17;216(1):85-91 PMID: 9714754
  6. Disruption of the Rb--Raf-1 interaction inhibits tumor growth and angiogenesis.
    Mol Cell Biol. 2004 Nov;24(21):9527-41 PMID: 15485920
  7. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis.
    Mol Cell Biol. 2001 Jul;21(14):4684-99 PMID: 11416145
  8. Intrinsic sexually dimorphic expression of the principal human CYP3A4 correlated with suboptimal activation of GH/glucocorticoid-dependent transcriptional pathways in men.
    Endocrinology. 2011 Dec;152(12):4813-24 PMID: 21952236
  9. Induction of ZEB proteins by inactivation of RB protein is key determinant of mesenchymal phenotype of breast cancer.
    J Biol Chem. 2012 Mar 9;287(11):7896-906 PMID: 22262832
  10. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E.
    Mol Cancer Res. 2011 Apr;9(4):440-7 PMID: 21454377
  11. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim.
    Gastroenterology. 2009 May;136(5):1689-700 PMID: 19422085
  12. Colorectal cancer migration and invasion initiated by microRNA-106a.
    PLoS One. 2012;7(8):e43452 PMID: 22912877
  13. The retinoblastoma tumor suppressor protein.
    Adv Cancer Res. 1994;64:25-85 PMID: 7879661
  14. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology.
    Nature. 2010 Jun 24;465(7301):1033-8 PMID: 20577206
  15. Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer.
    Endocr Relat Cancer. 2011 Apr 28;18(3):333-45 PMID: 21367843
  16. Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer.
    Cancer Res. 2007 Dec 15;67(24):11612-20 PMID: 18089790
  17. Control of pRB phosphorylation.
    Curr Opin Genet Dev. 1998 Feb;8(1):21-7 PMID: 9529601
  18. Cellular mechanisms of tumour suppression by the retinoblastoma gene.
    Nat Rev Cancer. 2008 Sep;8(9):671-82 PMID: 18650841
  19. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma.
    Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5003-8 PMID: 21383194
  20. Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation.
    Sci Signal. 2010 Apr 13;3(117):ra29 PMID: 20388916
  21. MicroRNAs in cancer: personalizing diagnosis and therapy.
    Ann N Y Acad Sci. 2010 Oct;1210:25-33 PMID: 20973796
  22. miR-93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8.
    Mol Endocrinol. 2012 Jun;26(6):1028-42 PMID: 22556343
  23. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer.
    Cancer Cell. 2008 Mar;13(3):272-86 PMID: 18328430
  24. MicroRNA involvement in the pathogenesis and management of breast cancer.
    J Clin Pathol. 2009 May;62(5):422-8 PMID: 19398594
  25. Sialic acid associated with αvβ3 integrin mediates HIV-1 Tat protein interaction and endothelial cell proangiogenic activation.
    J Biol Chem. 2012 Jun 8;287(24):20456-66 PMID: 22528484
  26. A DNA helicase activity is associated with an MCM4, -6, and -7 protein complex.
    J Biol Chem. 1997 Sep 26;272(39):24508-13 PMID: 9305914
  27. The retinoblastoma tumor-suppressor gene, the exception that proves the rule.
    Oncogene. 2006 Aug 28;25(38):5233-43 PMID: 16936742
  28. Association of RB/p16-pathway perturbations with DCIS recurrence: dependence on tumor versus tissue microenvironment.
    Am J Pathol. 2011 Sep;179(3):1171-8 PMID: 21756866
  29. Targeting the RB-pathway in cancer therapy.
    Clin Cancer Res. 2010 Feb 15;16(4):1094-9 PMID: 20145169
  30. Small RNA-mediated regulation of iPS cell generation.
    EMBO J. 2011 Mar 2;30(5):823-34 PMID: 21285944
  31. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma.
    Cancer Sci. 2009 Jul;100(7):1234-42 PMID: 19486339
  32. Adenosine 2B receptor expression is post-transcriptionally regulated by microRNA.
    J Biol Chem. 2010 Jun 11;285(24):18184-90 PMID: 20388705
  33. Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure.
    Oncogene. 2010 Jul 15;29(28):4018-32 PMID: 20473330
  34. Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action.
    Cancer Res. 2002 Nov 15;62(22):6587-97 PMID: 12438254
  35. Tailoring to RB: tumour suppressor status and therapeutic response.
    Nat Rev Cancer. 2008 Sep;8(9):714-24 PMID: 19143056
  36. Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition.
    Cancer Res. 2008 Jul 1;68(13):5104-12 PMID: 18593909
  37. MicroRNA-449 and microRNA-34b/c function redundantly in murine testes by targeting E2F transcription factor-retinoblastoma protein (E2F-pRb) pathway.
    J Biol Chem. 2012 Jun 22;287(26):21686-98 PMID: 22570483
  38. Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors.
    Cell Cycle. 2012 Jul 15;11(14):2756-61 PMID: 22767154
  39. microRNA involvement in human cancer.
    Carcinogenesis. 2012 Jun;33(6):1126-33 PMID: 22491715
  40. A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR.
    PLoS One. 2008;3(10):e3617 PMID: 18974881
  41. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.
    Oncogene. 2012 Dec 13;31(50):5162-71 PMID: 22286770
  42. Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells.
    Nat Cell Biol. 2012 Feb 26;14(3):266-75 PMID: 22366686
  43. A genetic variant in the promoter region of miR-106b-25 cluster and risk of HBV infection and hepatocellular carcinoma.
    PLoS One. 2012;7(2):e32230 PMID: 22393390
  44. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype.
    Genome Biol. 2007;8(10):R214 PMID: 17922911
  45. Proliferation and tumorigenesis of a murine sarcoma cell line in the absence of DICER1.
    Cancer Cell. 2012 Jun 12;21(6):848-55 PMID: 22698408
  46. The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas.
    Breast Cancer Res. 2008;10(5):R75 PMID: 18782450
  47. MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells.
    PLoS Genet. 2012;8(6):e1002751 PMID: 22685420
  48. Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6.
    J Med Chem. 2005 Apr 7;48(7):2388-406 PMID: 15801831
  49. Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis.
    Histopathology. 2005 Mar;46(3):307-13 PMID: 15720416
Article Info
Journal
Cell cycle (Georgetown, Tex.)
Abbr.
Cell Cycle
ISSN
1551-4005
Published
2013-01-01
Epub
2012-00-19
Pages
98-111
Language
English
Region
United States
NLM ID
101137841
PMCID
PMC3570523
Subset
IM
Grants
NCI NIH HHS · NCI CA12934 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com